We are live on
!
Find out more
Anika Therapeutics
ANIK
ANIK
170 hedge funds and large institutions have $446M invested in Anika Therapeutics in 2018 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 63 increasing their positions, 51 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
159% more call options, than puts
Call options by funds: $5.83M | Put options by funds: $2.25M
24% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 51
10.22% more ownership
Funds ownership: 84.32% → 94.54% (+10%)
8% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 24
0% more funds holding
Funds holding: 170 → 170 (0)
28% less capital invested
Capital invested by funds: $616M → $446M (-$170M)
Holders
170
Holders Change
–
Holders Change %
0%
% of All Funds
3.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
63
Reduced
51
Closed
24
Calls
$5.83M
Puts
$2.25M
Net Calls
+$3.57M
Net Calls Change
+$3.23M
Top Buyers
| 1 |
First Manhattan
New York
|
+$18.7M |
| 2 |
Morgan Stanley
New York
|
+$17.8M |
| 3 |
EC
Engaged Capital
Newport Beach,
California
|
+$10.8M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$9.71M |
| 5 |
BlackRock
New York
|
+$6.08M |
